KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medpace Holdings (MEDP) Treasury Shares (2016 - 2026)

Medpace Holdings filings provide 10 years of Treasury Shares readings, the most recent being $12.2 million for Q1 2026.

  • On a quarterly basis, Treasury Shares fell 0.65% to $12.2 million in Q1 2026 year-over-year; TTM through Mar 2026 was $12.2 million, a 0.65% decrease, with the full-year FY2025 number at $12.2 million, down 0.65% from a year prior.
  • Treasury Shares hit $69623.0 in Q1 2026 for Medpace Holdings, down from $324517.0 in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $627065.0 in Q1 2022 to a low of $69623.0 in Q1 2026.
  • Median Treasury Shares over the past 5 years was $324517.0 (2025), compared with a mean of $294940.0.
  • Biggest five-year swings in Treasury Shares: skyrocketed 155.34% in 2022 and later fell 13.49% in 2023.
  • Medpace Holdings' Treasury Shares stood at $12.5 million in 2022, then decreased by 1.4% to $12.3 million in 2023, then fell by 0.71% to $12.2 million in 2024, then decreased by 0.65% to $12.2 million in 2025, then changed by 0.0% to $12.2 million in 2026.
  • The last three reported values for Treasury Shares were $12.2 million (Q1 2026), $12.2 million (Q4 2025), and $12.2 million (Q3 2025) per Business Quant data.